P-412 Real World Outcomes with Elotuzumab-Based Therapies for Patients with Relapsed Refractory Multiple Myeloma (RRMM): A Mayo Clinic Experience
Saved in:
Published in | Clinical lymphoma, myeloma and leukemia Vol. 24; pp. S272 - S273 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.09.2024
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 2152-2650 |
---|---|
DOI: | 10.1016/S2152-2650(24)02314-0 |